The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don’t have diabetes, whether or not they also have impaired kidney function, according to new research to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).
Cardiologists Float Idea of Unionization Among Ways to Protect Employee Physicians
LONG BEACH, Calif. — Even recognized cardiology leaders have not been immune from threats and abuse by their hospital employers, prompting an emotional discussion on
May 6, 2024